MILESTONE SCIENTIFIC INC. — Director's Dealing 2017

Jan 11, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MILESTONE SCIENTIFIC INC. (MLSS)
CIK: 0000855683
Period of Report: 2017-01-09

Reporting Person: D'Agostino Joseph (CFO & COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-01-09	Common Stock	A	24845	—	Acquired	1267163	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-09	Options to purchase common stock	$1.61	A	49689	Acquired	2022-01-09	Common Stock, par value $.001 (49689)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to purchase common stock	$1.7200	2021-02-04	Common Stock, par value $.001 per share (133140)	133140	Direct
Options to purchase common stock	$1.2800	2017-12-31	Common Stock, par value $.001 per share (78126)	78126	Direct
Options to purchase common stock	$1.5000	2018-12-31	Common Stock, par value $.001 per share (66666)	66666	Direct
Options to purchase common stock	$2.0900	2019-11-11	Common Stock, par value $.001 per share (150000)	150000	Direct
Options to purchase common stock	$2.0300	2019-11-20	Common Stock, par value $.001 per share (49261)	49261	Direct

Footnotes

F1: 191,046 of these shares are issuable to the reporting person at the termination of employment.

F2: Immediately.

F3: Not applicable.

F4: These options are exercisable as follows: (i) immediately for 44,380 shares on the date of grant (2-4-16); and (ii) for an additional 1/3 of the 88,760 remaining shares on each of the 1st through 3rd anniversaries of the date of grant.

F5: These options are exercisable as follows: (i) immediately for 116,667 shares; and (ii) for an additional 33,333 on the 3rd anniversary of the (11-11-14) date of grant.

F6: These options are exercisable as follows: (i) immediately for 38,315 shares; and (ii) for an additional 10,946 on the 3rd anniversary of the (11-20-14) date of grant.

F7: These options are exercisable as follows: (i) immediately for 16,563 shares on the date of grant (1-9-17); and (ii) for an additional 1/3 of the 33,126 remaining shares on each of the 1st through 3rd anniversaries of the date of grant.